First experiences in treatment of low-grade glioma grade I and II with proton therapy

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Hauswald, Henrik ^a   Rieken, Stefan ^a   Ecker, Swantje ^a   Kessel, Kerstin A ^a   Herfarth, Klaus ^a   Debus, Jürgen ^a   Combs, Stephanie E ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Brain tumor; Glioma; Ion therapy; Low grade glioma; Particle therapy; Proton therapy

Indexed keywords

ADOLESCENT; ADULT; ALOPECIA; AMNESIA; ARTICLE; ASTROCYTOMA; BRAIN EDEMA; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER REGRESSION; CHILD; CLINICAL ARTICLE; FATIGUE; FEMALE; FIBRILLARY ASTROCYTOMA; FOLLOW UP; GLIOMA; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOCYTIC ASTROCYTOMA; PRESCHOOL CHILD; PROTON THERAPY; RADIATION DOSE; SCHOOL CHILD; SHORT TERM MEMORY; SPEECH DISORDER; TREATMENT RESPONSE; TUMOR BIOPSY; TUMOR GROWTH; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; ALOPECIA; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FATIGUE; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; PROTON THERAPY; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84868598923     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-189     Document Type: Article

References (15)

1. Crocetti E, Trama A, Stiller C, Caldarella A, Soffietti R, Jaal J, Weber DC, Ricardi U, Slowinski J, Brandes A. Epidemiology of glial and non-glial brain tumours in Europe 1990, Oxford, England: European Journal of Cancer, 2012.
2. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 1993, 3:255-268. 10.1111/j.1750-3639.1993.tb00752.x, 8293185.
3. van den Bent MJ, Wefel JS, Schiff D, Taphoorn MJB, Jaeckle K, Junck L, Armstrong T, Choucair A, Waldman AD, Gorlia T, Chamberlain M, Baumert BG, Vogelbaum MA, Macdonald DR, Reardon DA, Wen PY, Chang SM, Jacobs AH. Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol 2011, 12:583-593. 10.1016/S1470-2045(11)70057-2, 21474379.
4. Brown PD, Buckner JC, Uhm JH, Shaw EG. The neurocognitive effects of radiation in adult low-grade glioma patients. Neuro Oncol 2003, 5:161-167. 10.1215/S1152851702000431, 1920683, 12816722.
5. Beltran C, Roca M, Merchant TE. On the benefits and risks of proton therapy in pediatric craniopharyngioma. Int J Radiat Oncol Biol Phys 2012, 82:e281-e287. 10.1016/j.ijrobp.2011.01.005, 21570209.
6. Athar BS, Paganetti H. Comparison of second cancer risk due to out-of-field doses from 6-MV IMRT and proton therapy based on 6 pediatric patient treatment plans. Radiother Oncol 2011, 98:87-92. 10.1016/j.radonc.2010.11.003, 3056442, 21159398.
7. Galloway TJ, Indelicato DJ, Amdur RJ, Swanson EL, Smith AA, Marcus RB. Second tumors in pediatric patients treated with radiotherapy to the central nervous system. Am J Clin Oncol 2011, [Epub ahead of print] PubMed PMID: 21383606.
8. Hug EB, Muenter MW, Archambeau JO, DeVries A, Liwnicz B, Loredo LN, Grove RI, Slater JD. Conformal proton radiation therapy for pediatric low-grade astrocytomas. Strahlenther Onkol 2002, 178:10-17. 10.1007/s00066-002-0874-2, 11977386.
9. Hasegawa A, Mizoe J-E, Tsujii H, Kamada T, Jingu K, Iwadate Y, Nakazato Y, Matsutani M, Takakura K. Experience With Carbon Ion Radiotherapy for WHO Grade 2 Diffuse Astrocytomas. Int J Radiat Oncol Biol Phys 2012, 83:100-106. 10.1016/j.ijrobp.2011.06.1952, 22104357.
10. Ruben JD, Dally M, Bailey M, Smith R, McLean CA, Fedele P. Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy. Int J Radiat Oncol Biol Phys 2006, 65:499-508. 10.1016/j.ijrobp.2005.12.002, 16517093.
11. Meyzer C, Dhermain F, Ducreux D, Habrand J-L, Varlet P, Sainte-Rose C, Dufour C, Grill J. A case report of pseudoprogression followed by complete remission after proton-beam irradiation for a low-grade glioma in a teenager: the value of dynamic contrast-enhanced MRI. Radiat Oncol 2010, 5:9. 10.1186/1748-717X-5-9, 2829589, 20132555.
12. Hu LS, Baxter LC, Smith KA, Feuerstein BG, Karis JP, Eschbacher JM, Coons SW, Nakaji P, Yeh RF, Debbins J, Heiserman JE. Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements. AJNR Am J Neuroradiol 2009, 30:552-558. 10.3174/ajnr.A1377, 19056837.
13. Schlemmer HP, Bachert P, Herfarth KK, Zuna I, Debus J, van Kaick G. Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. AJNR Am J Neuroradiol 2001, 22:1316-1324.
14. Vöglein J, Tüttenberg J, Weimer M, Gerigk L, Kauczor H-U, Essig M, Weber M-A. Treatment monitoring in gliomas: comparison of dynamic susceptibility-weighted contrast-enhanced and spectroscopic MRI techniques for identifying treatment failure. Invest Radiol 2011, 46:390-400. 10.1097/RLI.0b013e31820e1511, 21285888.
15. Malkinson FD, Keane JT. Radiobiology of the skin: review of some effects on epidermis and hair. J Invest Dermatol 1981, 77:133-138. 10.1111/1523-1747.ep12479347, 7252246.